Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days £260.00 £353.00 Friday, 10th May 2024 HCM.L stock ended at £352.00. This is 13.55% more than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 3.22% from a day low at £342.00 to a day high of £353.00.
90 days £202.50 £353.00
52 weeks £173.60 £353.00

Historical Hutchison China Meditech Ltd ADR (Sponsored) prices

Date Open High Low Close Volume
Jan 23, 2024 £211.00 £222.00 £210.85 £220.50 168 388
Jan 22, 2024 £223.50 £225.49 £207.00 £210.50 169 403
Jan 19, 2024 £244.50 £244.50 £221.00 £222.00 299 898
Jan 18, 2024 £240.62 £242.00 £232.89 £240.50 108 938
Jan 17, 2024 £242.71 £248.00 £235.50 £237.00 45 512
Jan 16, 2024 £250.00 £264.00 £250.00 £252.50 43 093
Jan 15, 2024 £251.80 £255.00 £251.50 £251.50 7 130
Jan 12, 2024 £251.46 £259.99 £251.33 £254.50 38 549
Jan 11, 2024 £265.00 £265.74 £258.50 £259.50 55 409
Jan 10, 2024 £253.40 £259.50 £248.50 £251.00 7 663
Jan 09, 2024 £257.50 £258.50 £246.30 £253.00 14 138
Jan 08, 2024 £252.50 £259.00 £247.50 £251.00 69 309
Jan 05, 2024 £275.00 £275.00 £262.75 £264.00 27 063
Jan 04, 2024 £275.00 £277.00 £269.50 £270.50 27 132
Jan 03, 2024 £277.00 £280.50 £271.00 £271.00 27 548
Jan 02, 2024 £280.00 £283.50 £273.70 £280.00 14 638
Dec 29, 2023 £285.50 £289.50 £280.00 £283.00 24 811
Dec 28, 2023 £280.00 £280.00 £280.00 £280.00 0
Dec 27, 2023 £272.00 £275.00 £270.13 £270.50 22 361
Dec 22, 2023 £272.40 £280.00 £260.50 £280.00 1 459
Dec 21, 2023 £272.00 £272.00 £272.00 £272.00 0
Dec 20, 2023 £278.00 £289.50 £267.50 £272.00 46 494
Dec 19, 2023 £288.00 £288.00 £271.15 £282.00 51 828
Dec 18, 2023 £300.00 £300.00 £282.00 £289.50 52 472
Dec 15, 2023 £300.50 £308.00 £300.50 £308.00 183 102
Click to get the best stock tips daily for free!

About Hutchison China Meditech Ltd ADR (Sponsored)

Hutchison China Meditech Ltd ADR (Sponsored) HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and renal cell carcinoma, colorectal cancer (CRC), and gastric cancer (GC); and Fruquintinib, an inhibitor for ... HCM.L Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT